Dalian Zhao

This inventor holds 20 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Merck + Co., Inc., Velicept Therapeutics, Inc., B3ar Therapeutics, Inc.. Active years: 1992-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dalian Zhao. Retrieved from https://idiyas.com/inventor/dalian-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 2)

% Patents Active = 90.0

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 32(Granted Patents)

Location History:

Scotch Plains, NJ (US) (1992 - 1994)
Fanwood, NJ (US) (1997 - 2024)

Company Filing History:

Velicept Therapeutics, Inc.

patents

2 out of 2

B3ar Therapeutics, Inc.

patents

4. 2 out of 106

Dupont Pharmaceuticals Company

patents

5. 2 out of 16

Pliant Therapeutics, Inc.

patents

6. 1 out of 2,405

Merck Sharp + Dohme Corp.

patents

7. 1 out of 1

Mirati Therapepeutics, Inc.

patent

8. 1 out of 834,659

Other

patents

Years Active: 1992-2026

Loading Chart...

Areas of Expertise:

Integrin Inhibitor

Solabegron Zwitterion

Antidiabetic Compounds

Chiral Mediator

Benzoxazinones

Fibrinogen Receptor Antagonists

Methylthiophenyl Hydroxyketones

Pyridyl Ethylation

Indoles

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12637462 - Integrin inhibitor and uses thereof (2026-05-26),

2. 12435026 - Solabegron zwitterion and uses thereof (2025-10-07),

3. 12018025 - Integrin inhibitor and uses thereof (2024-06-25),

4. 11787819 - Crystalline salt of a multi-tyrosine kinase inhibitor, method of preparation, and use thereof (2023-10-17),

5. 11691944 - Solabegron zwitterion and uses thereof (2023-07-04),

6. 10844004 - Solabegron zwitterion and uses thereof (2020-11-24),

7. 10221126 - Solabegron zwitterion and uses thereof (2019-03-05),

8. 10065922 - Solabegron zwitterion and uses thereof (2018-09-04),

9. 7683092 - Crystalline forms of antidiabetic compounds (2010-03-23),

10. 6281391 - Synthesis of methylthiophenyl hydroxyketones (2001-08-28),

11. 6040480 - Asymmetric synthesis of benzoxazinones (2000-03-21),

12. 5925789 - Asymmetric synthesis of benzoxazinones (1999-07-20),

13. 5856492 - Efficient synthesis of a chiral mediator (1999-01-05),

14. 5792871 - Process for (1998-08-11),

15. 5686607 - Pyridyl ethylation of lactam derivatives (1997-11-11),

Title: Dalian Zhao: Innovator in Pharmaceutical Sciences

Introduction

Dalian Zhao is a prominent inventor based in Fanwood, NJ (US), known for his significant contributions to pharmaceutical sciences. With a total of 19 patents to his name, Zhao has made remarkable advancements in the treatment of various medical conditions, particularly those related to urinary tract symptoms and fibrotic diseases.

Latest Patents

Among his latest patents is the application for solabegron zwitterion and its uses. This innovative application focuses on treating lower urinary tract symptoms, such as overactive bladder and prostate disorders. It also encompasses pharmaceutical compositions and methods of treatment utilizing solabegron zwitterion. Additionally, Zhao has developed methods for preparing solabegron hydrochloride from the zwitterion. Another notable patent involves integrin inhibitors and their uses. This application provides compositions and methods for integrin inhibitors, including crystalline forms of salts of the inhibitors. The data presented includes X-ray powder diffraction, thermogravimetric analysis, and differential scanning calorimetry for the crystalline forms, which are useful in treating fibrotic diseases.

Career Highlights

Dalian Zhao has had a distinguished career, working with leading companies in the pharmaceutical industry. He has been associated with Merck & Company, Inc. and Velicept Therapeutics, Inc., where he has contributed to groundbreaking research and development efforts.

Collaborations

Throughout his career, Zhao has collaborated with notable professionals in the field, including Raymond E. Stevens and Bingidimi Itute Mobele. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Dalian Zhao's work in pharmaceutical sciences exemplifies the impact of innovation on healthcare. His patents and collaborations reflect a commitment to advancing medical treatments and improving patient outcomes.

Profile summary based on public USPTO records.